Bill
H 1364
Overview: H 1364, "An Act relative to promoting healthcare access and affordability for patients", has been reported favorably by the committee and referred to the House Ways and M
Overview: H 1364, "An Act relative to promoting healthcare access and affordability for patients", has been reported favorably by the committee and referred to the House Ways and Means Committee. The bill was introduced on February 27, 2025.
Purpose and Intent: The main goal of this bill is to improve healthcare access and affordability for patients by implementing various measures, such as increasing transparency, regulating prescription drug prices, and expanding coverage options.
Key Provisions:
- Requires healthcare providers and insurers to disclose the actual cost of healthcare services and procedures
- Establishes a prescription drug affordability board to set upper payment limits for certain high-cost medications
- Expands Medicaid eligibility and creates a public health insurance option for individuals and small businesses
Affected Parties and Impacts: The bill would primarily benefit patients by making healthcare more accessible and affordable. It would also impact healthcare providers, insurers, and pharmaceutical companies, who would be subject to new regulations and requirements.
Procedural and Timeline Considerations: The bill has been reported favorably by the committee and referred to the House Ways and Means Committee for further consideration. The timeline for the bill's progress through the legislative process is unclear at this stage.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
